Skip to content

Pathway TR-20C

by Prometheus Group of New Hampshire Limited, the

Pathway TR-20C (8625) is a Class II device made by Prometheus Group of New Hampshire Limited, the, listed in FDA GUDID since 26 Sep 2016 (UDI-DI 00852423006158), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00852423006158 UDI-DI Date26 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Pathway
Generic name
Psychophysiological biofeedback system
Model / Ref / Catalog
TR-20C, 8625
Primary DI / UDI-DI
00852423006158
FDA product code
HCC
GMDN term
Psychophysiological biofeedback system
Device class
Class II
Regulation number
882.5050
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Psychophysiological biofeedback system.

Other devices from Prometheus Group of New Hampshire Limited, the

See all devices from Prometheus Group of New Hampshire Limited, the →

Properties

  • Prescription use
  • Premarket exempt
  • Serial number
  • Manufacturing date
Other properties (11, all answered No)